BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 27007511)

  • 1. Cytological Diagnosis of Follicular Variant of Papillary Thyroid Carcinoma before and after the Bethesda System for Reporting Thyroid Cytopathology.
    Fazeli R; VandenBussche CJ; Bishop JA; Ali SZ
    Acta Cytol; 2016; 60(1):14-8. PubMed ID: 27007511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the modification of the diagnostic criteria in the 2017 Bethesda System for Reporting Thyroid Cytopathology: a report of a single institution in Japan.
    Higuchi M; Hirokawa M; Kanematsu R; Tanaka A; Suzuki A; Yamao N; Hayashi T; Kuma S; Miyauchi A
    Endocr J; 2018 Dec; 65(12):1193-1198. PubMed ID: 30282887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytopathology of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: A comparative study with similar patterned papillary thyroid carcinoma variants.
    Mahajan S; Agarwal S; Kocheri N; Jain D; Mathur SR; Iyer VK
    Cytopathology; 2018 Jun; 29(3):233-240. PubMed ID: 29638022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists.
    Padmanabhan V; Marshall CB; Akdas Barkan G; Ghofrani M; Laser A; Tolgay Ocal I; David Sturgis C; Souers R; Kurtycz DF
    Diagn Cytopathol; 2017 May; 45(5):399-405. PubMed ID: 28217980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology.
    Faquin WC; Wong LQ; Afrogheh AH; Ali SZ; Bishop JA; Bongiovanni M; Pusztaszeri MP; VandenBussche CJ; Gourmaud J; Vaickus LJ; Baloch ZW
    Cancer Cytopathol; 2016 Mar; 124(3):181-7. PubMed ID: 26457584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status and diagnostic values of the Bethesda system for reporting thyroid cytopathology in a papillary thyroid carcinoma-prevalent area.
    Lee YB; Cho YY; Jang JY; Kim TH; Jang HW; Chung JH; Oh YL; Kim SW
    Head Neck; 2017 Feb; 39(2):269-274. PubMed ID: 27617626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
    Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
    Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The triage efficacy of fine needle aspiration biopsy for follicular variant of papillary thyroid carcinoma using the Bethesda reporting guidelines.
    Kurian EM; Dawlett M; Wang J; Gong Y; Guo M
    Diagn Cytopathol; 2012 May; 40 Suppl 1():E69-73. PubMed ID: 21538966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Noninvasive Follicular Variant of Papillary Thyroid Carcinoma on Rates of Malignancy for Fine-Needle Aspiration Diagnostic Categories.
    Strickland KC; Howitt BE; Marqusee E; Alexander EK; Cibas ES; Krane JF; Barletta JA
    Thyroid; 2015 Sep; 25(9):987-92. PubMed ID: 26114752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Review and Meta-analysis of the Impact of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Cytological Diagnosis and Thyroid Cancer Prevalence.
    Ruanpeng D; Cheungpasitporn W; Thongprayoon C; Hennessey JV; Shrestha RT
    Endocr Pathol; 2019 Sep; 30(3):189-200. PubMed ID: 31338752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
    Yazgan A; Balci S; Dincer N; Kiyak G; Tuzun D; Ersoy R; Cakir B; Guler G
    Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.
    Sullivan PS; Hirschowitz SL; Fung PC; Apple SK
    Cancer Cytopathol; 2014 Dec; 122(12):866-72. PubMed ID: 25078420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing noninvasive follicular thyroid neoplasm with papillary-like nuclear features may potentially impact the risk of malignancy for thyroid nodules categorized as AUS/FLUS and FN/SFN.
    Li W; Sciallis A; Lew M; Pang J; Jing X
    Diagn Cytopathol; 2018 Feb; 46(2):148-153. PubMed ID: 29193839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Is Not a Cytological Diagnosis, but It Influences Cytological Diagnosis Outcomes: A Systematic Review and Meta-Analysis.
    Haaga E; Kalfert D; Ludvíková M; Kholová I
    Acta Cytol; 2022; 66(2):85-105. PubMed ID: 34781293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytological Diagnoses Associated with Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features According to the Bethesda System for Reporting Thyroid Cytopathology: A Systematic Review and Meta-Analysis.
    Bongiovanni M; Giovanella L; Romanelli F; Trimboli P
    Thyroid; 2019 Feb; 29(2):222-228. PubMed ID: 30426887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Bethesda system for reporting thyroid cytopathology: an institutional experience of the outcome of indeterminate categories.
    Onder S; Firat P; Ates D
    Cytopathology; 2014 Jun; 25(3):177-84. PubMed ID: 23998291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancy risk and reproducibility associated with atypia of undetermined significance on thyroid cytology.
    Mathur A; Najafian A; Schneider EB; Zeiger MA; Olson MT
    Surgery; 2014 Dec; 156(6):1471-6; discussion1476. PubMed ID: 25218896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Concept of the Encapsulated Follicular Variant of Papillary Thyroid Carcinoma and Its Impact on the Bethesda System for Reporting Thyroid Cytopathology: A Single-Institute Experience.
    Canberk S; Gunes P; Onenerk M; Erkan M; Kilinc E; Kocak Gursan N; Kilicoglu GZ
    Acta Cytol; 2016; 60(3):198-204. PubMed ID: 27414983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated?
    Straccia P; Rossi ED; Bizzarro T; Brunelli C; Cianfrini F; Damiani D; Fadda G
    Cancer Cytopathol; 2015 Dec; 123(12):713-22. PubMed ID: 26355876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the Reclassification of "Noninvasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma" to "Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features" on the Bethesda System for Reporting Thyroid Cytopathology: A Large Academic Institution's Experience.
    Lau RP; Paulsen JD; Brandler TC; Liu CZ; Simsir A; Zhou F
    Am J Clin Pathol; 2017 Dec; 149(1):50-54. PubMed ID: 29272354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.